Filing Details
- Accession Number:
- 0000929638-20-000753
- Form Type:
- 13D Filing
- Publication Date:
- 2020-07-20 09:51:59
- Filed By:
- Tybourne Capital Management
- Company:
- Bicycle Therapeutics Plc (NASDAQ:BCYC)
- Filing Date:
- 2020-07-20
- SEC Url:
- 13D Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Tybourne Capital Management (HK) Limited | 0 | 1,957,961 | 0 | 1,957, | 1,957, | 10.8% |
| Tybourne Capital Management Limited | 0 | 1,957, | 0 | 1,957, | 1,957, | 10.8% |
| Tybourne Kesari Limited | 0 | 1,957, | 0 | 1,957, | 1,957, | 10.8% |
| Viswanathan Krishnan | 0 | 1,957, | 0 | 1,957, | 1,957, | 10.8% |
| Aquila Investments IV | 0 | 1,593,675 | 0 | 1, | 1, | 8.8% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Bicycle Therapeutics Limited
(Name of Issuer)
Ordinary Shares
(Title of Class of Securities)
088786108 **
(CUSIP Number)
(CUSIP Number)
Catherine Cheung
Tybourne Capital Management (HK) Limited
30/F, AIA Central
1 Connaught Road Central
Hong Kong, K3
Tel. No.: 852-3983-6800
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
Receive Notices and Communications)
June 30, 2020
(Date of Event which Requires Filing of this Statement)
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because
of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
** Cusip number relates to the American Depositary Shares representing Ordinary Shares. References herein to “Ordinary
Shares” include Ordinary Shares underlying American Depositary Shares.
| 1 | Names of Reporting Persons. Tybourne Capital Management (HK) Limited | |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |
| (a) [ ] | ||
| (b) [ ] | ||
| 3 | SEC Use Only | |
| 4 | Source of Funds (See Instructions): AF | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e): [ ] | |
| 6 | Citizenship or Place of Organization. Hong Kong |
| Number of Shares Beneficially Owned by Each Reporting Person With | 7 Sole Voting Power 0 |
| 8 Shared Voting
Power 1,957,961 | |
| 9 Sole Dispositive Power 0 | |
| 10 Shared
Dispositive Power 1,957, 961 |
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,957, 961 | ||
| 12 | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] | ||
| 13 | Percent of Class Represented by Amount in Row (11) 10.8% | ||
| 14 | Type of Reporting Person (See Instructions) IA |
| 1 | Names of Reporting Persons. Tybourne Capital Management Limited | |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |
| (a) [ ] | ||
| (b) [ ] | ||
| 3 | SEC Use Only | |
| 4 | Source of Funds (See Instructions): AF | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e): [ ] | |
| 6 | Citizenship or Place of Organization. Cayman Islands |
| Number of Shares Beneficially Owned by Each Reporting Person With | 7 Sole Voting Power 0 |
| 8 Shared Voting
Power 1,957, 961 | |
| 9 Sole Dispositive Power 0 | |
| 10 Shared
Dispositive Power 1,957, 961 |
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,957, 961 | ||
| 12 | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] | ||
| 13 | Percent of Class Represented by Amount in Row (11) 10.8% | ||
| 14 | Type of Reporting Person (See Instructions) HC |
| 1 | Names of Reporting Persons. Tybourne Kesari Limited | |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |
| (a) [ ] | ||
| (b) [ ] | ||
| 3 | SEC Use Only | |
| 4 | Source of Funds (See Instructions): Cayman Islands | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e): [ ] | |
| 6 | Citizenship or Place of Organization. Cayman Islands |
| Number of Shares Beneficially Owned by Each Reporting Person With | 7 Sole Voting Power 0 |
| 8 Shared Voting
Power 1,957, 961 | |
| 9 Sole Dispositive Power 0 | |
| 10 Shared
Dispositive Power 1,957, 961 |
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,957, 961 | ||
| 12 | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] | ||
| 13 | Percent of Class Represented by Amount in Row (11) 10.8% | ||
| 14 | Type of Reporting Person (See Instructions) HC |
| 1 | Names of Reporting Persons. Viswanathan Krishnan | |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |
| (a) [ ] | ||
| (b) [ ] | ||
| 3 | SEC Use Only | |
| 4 | Source of Funds (See Instructions): AF | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e): [ ] | |
| 6 | Citizenship or Place of Organization. United Kingdom |
| Number of Shares Beneficially Owned by Each Reporting Person With | 7 Sole Voting Power 0 |
| 8 Shared Voting
Power 1,957, 961 | |
| 9 Sole Dispositive Power 0 | |
| 10 Shared
Dispositive Power 1,957, 961 |
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,957, 961 | ||
| 12 | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] | ||
| 13 | Percent of Class Represented by Amount in Row (11) 10.8% | ||
| 14 | Type of Reporting Person (See Instructions) HC, IN |
| 1 | Names of Reporting Persons. Aquila Investments IV | |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |
| (a) [ ] | ||
| (b) [ ] | ||
| 3 | SEC Use Only | |
| 4 | Source of Funds (See Instructions): WC | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e): [ ] | |
| 6 | Citizenship or Place of Organization. Cayman Islands |
| Number of Shares Beneficially Owned by Each Reporting Person With | 7 Sole Voting Power 0 |
| 8 Shared Voting Power 1,593,675 | |
| 9 Sole Dispositive Power 0 | |
| 10 Shared Dispositive Power 1,593,675 |
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,593,675 | ||
| 12 | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] | ||
| 13 | Percent of Class Represented by Amount in Row (11) 8.8% | ||
| 14 | Type of Reporting Person (See Instructions) OO |
AMENDMENT NO. 1 TO SCHEDULE 13D
This Amendment No. 1 to Schedule 13D (the “Amendment”) relates to Ordinary Shares (“Ordinary Shares”) of Bicycle Therapeutics Limited, a limited company organized under the laws od
England and Wales (the “Issuer” or the “Company”). This Amendment is being filed to amend the Schedule 13D that was originally filed on June 3, 2019 (the “Schedule 13D”). Unless otherwise indicated in this Amendment, all capitalized terms have the
meanings ascribed to them in the Schedule 13D.
This Amendment is being filed to amend Item 4 of the Schedule 13D.
Item 4 is hereby supplemented as follows:
Bosun Hau, who serves as Managing Director and Principal – Private Markets at Tybourne HK, ceased serving as a Director of the Issuer as of June 30, 2020.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and
correct.
Date: July 20, 2020
TYBOURNE CAPITAL MANAGEMENT (HK) LIMITED
By: /s/ Catherine Cheung
Catherine Cheung, Chief Operating Officer
TYBOURNE CAPITAL MANAGEMENT LIMITED
By: /s/ Viswanathan Krishnan
By: /s/ Viswanathan Krishnan
Viswanathan Krishnan, Principal
TYBOURNE KESARI LIMITED
By: /s/ Viswanathan Krishnan
Viswanathan Krishnan, Principal
/s/ Viswanathan Krishnan
AQUILA INVESTMENTS IV
By: Tybourne Kesari Limited, Director
By: /s/ Viswanathan Krishnan
Viswanathan Krishnan, Principal